{
  "ticker": "LLY",
  "target_date": "2025-09-09",
  "actual_date": "2025-09-09",
  "collected_at": "2025-12-08T12:15:31.878338",
  "price": {
    "open": 733.1,
    "high": 751.74,
    "low": 732.79,
    "close": 749.50927734375,
    "volume": 2986900,
    "change_1d_pct": 1.62,
    "change_7d_pct": 2.55,
    "change_30d_pct": -6.91
  },
  "technicals": {
    "rsi_14": 69.81,
    "sma_20": 712.55,
    "sma_50": 741.4,
    "macd": 2.847,
    "macd_signal": -3.323,
    "macd_histogram": 6.17,
    "bb_upper": 770.98,
    "bb_lower": 654.11,
    "price_vs_sma20_pct": 5.19,
    "price_vs_sma50_pct": 1.09,
    "volume_ratio": 0.65
  },
  "fundamentals": {
    "market_cap": 892575088640,
    "pe_ratio": 48.78344,
    "forward_pe": 43.93954,
    "price_to_book": 37.487576,
    "price_to_sales": 15.021509,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.46,
    "pct_from_52w_low": 59.62
  },
  "macro": {
    "spy": {
      "price": 648.53,
      "change_1d_pct": 0.23,
      "change_7d_pct": 0.82
    },
    "vix": {
      "level": 15.04,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.07
    },
    "dollar_index": {
      "level": 97.79
    },
    "gold": {
      "price": 3643.3
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Lilly to give biotech startups access to AI tools",
      "source": "Yahoo",
      "datetime": 1757440740,
      "summary": "Insitro, Firefly Bio and Superluminal Medicines are among the first participants in Lilly\u2019s \u201cTuneLabs\u201d platform, which the pharma says can help young drugmakers while training its own models.",
      "url": "https://finnhub.io/api/news?id=4f62422493af24d1aec3be477ebf8d0ff4c55e34ad4a1f91789da6593a16ec80"
    },
    {
      "headline": "Metsera: An Emerging Contender In The GLP\u20111 Arena",
      "source": "SeekingAlpha",
      "datetime": 1757438822,
      "summary": "Discover Metsera's potential in the obesity drug market. Learn why I rate it a HOLD amid upcoming trial results.",
      "url": "https://finnhub.io/api/news?id=6ef362478f8ffcc2e5175cbb3c2475dcb875cc039a69581a2a4536975b4fd9c8"
    },
    {
      "headline": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
      "source": "MarketWatch",
      "datetime": 1757435460,
      "summary": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=ceb729f41cca94dd339e8cd8c28c6be96fecf3ba59b4ad67653fa13cb2469f33"
    },
    {
      "headline": "Wall Street Lunch: US Labor Market Sees Big Downward Revisions",
      "source": "SeekingAlpha",
      "datetime": 1757425362,
      "summary": "The U.S. added 911,000 fewer jobs in the 12 months through March 2025, the Bureau of Labor Statistics\u00e2\u0080\u0099 preliminary benchmark revision showed.",
      "url": "https://finnhub.io/api/news?id=ff65d69942f53746134e0ffb7ae63020fb38903a93a19562b13be67d3c035ddd"
    },
    {
      "headline": "1 Reason Every Investor Should Know About Novo Nordisk (NVO)",
      "source": "Yahoo",
      "datetime": 1757383200,
      "summary": "The company could be on the verge of turning the tide in the battle over weight loss drugs.",
      "url": "https://finnhub.io/api/news?id=8d12542add7028450ccef2e307cd462ea2fcad3289913ecf7372acf68fd6784d"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-09-08",
      "description": "xslF345X05/wk-form4_1757362781.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000238/xslF345X05/wk-form4_1757362781.xml"
    },
    {
      "form": "4",
      "date": "2025-08-28",
      "description": "xslF345X05/wk-form4_1756412129.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000236/xslF345X05/wk-form4_1756412129.xml"
    },
    {
      "form": "4",
      "date": "2025-08-28",
      "description": "xslF345X05/wk-form4_1756412046.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000234/xslF345X05/wk-form4_1756412046.xml"
    },
    {
      "form": "8-K",
      "date": "2025-08-20",
      "description": "d929636d8k.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000119312525184093/d929636d8k.htm"
    },
    {
      "form": "4",
      "date": "2025-08-19",
      "description": "xslF345X05/wk-form4_1755634987.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000232/xslF345X05/wk-form4_1755634987.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}